Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin in Unexplained Recurrent Spontaneous Abortion
NCT00740545Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Apr 2007
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in recurrent spontaneous abortion (RPL), sponsored by Centre Hospitalier Universitaire de Brest. Started Apr 2007; status: terminated.
02
Drugs
enoxaparin
03
Conditions
recurrent spontaneous abortion (RPL)
Beyond the preview
Go deeper on NCT00740545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740545.